Ms. Ching-Yi Tsai, Ph.D. received her doctoral degree in Microbiology and Immunology from Dartmouth College. Dr. Tsai started her research career on characterization and cloning the caleosin in oil bodies of plant seeds. She later focused her research interest on viruses at National Taiwan University Medical School. Her research projects included the studies of SARS virus and hepatitis B virus. Her study included the identification and whole genome sequences of SARS virus in patients in Taiwan. She set up the quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis. Her doctoral research in Dartmouth College focused on viral-immunology. She studied immune-based therapies that control virus infections. Dr. Tsai continued her postdoctoral research at the University of Pennsylvania Medical School. She studied and characterized the biophysics mechanisms affecting the function of antigen chimericreceptors (CARs) and developing new chimeric receptors targeting different tumors.
Dr. Tsai joined Prestige Enviromicrobiology in 2015 and focused on developing new DNA-based methods for the detection of important environmental microorganisms, such as Legionella, Enterococcus and Mycobacterium. She completed and received certification on a three-day workshop titled "Food and Indoor Fungi" at CBS-KNAW (the Royal Netherlands Academy of Arts and Sciences) Fungal Biodiversity Centre, the Netherlands in 2016. She also completed and received certification on a workshop titled "Quality Assurance/Control Management in Microbiological Laboratory" at Taiwan Testing and Quality Assurance Society in 2018. Dr. Tsai is current a member in American Industrial Hygiene Association and IEQ Committee for American Industrial Hygiene Association.